"Pressoreceptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.
Descriptor ID |
D011311
|
MeSH Number(s) |
A08.675.650.915.750.750 A08.800.050.800.900.700 A08.800.950.750.750 A11.671.650.915.750.750
|
Concept/Terms |
Pressoreceptors- Pressoreceptors
- Pressoreceptor
- Stretch Receptors, Vascular
- Receptor, Vascular Stretch
- Receptors, Vascular Stretch
- Stretch Receptor, Vascular
- Vascular Stretch Receptor
- Vascular Stretch Receptors
- Stretch Receptors, Arterial
- Arterial Stretch Receptor
- Arterial Stretch Receptors
- Receptor, Arterial Stretch
- Receptors, Arterial Stretch
- Stretch Receptor, Arterial
- Receptors, Stretch, Vascular
- Baroreceptors
- Baroreceptor
- Receptors, Stretch, Arterial
|
Below are MeSH descriptors whose meaning is more general than "Pressoreceptors".
Below are MeSH descriptors whose meaning is more specific than "Pressoreceptors".
This graph shows the total number of publications written about "Pressoreceptors" by people in this website by year, and whether "Pressoreceptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pressoreceptors" by people in Profiles.
-
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. BMC Cardiovasc Disord. 2021 03 26; 21(1):155.
-
Carotid baroreceptor stimulation blood pressure response mapped in patients undergoing carotid endarterectomy (C-Map study). Auton Neurosci. 2016 12; 201:60-67.
-
The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board. J Clin Hypertens (Greenwich). 2012 Mar; 14(3):184-6.
-
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
-
Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension. 1998 Oct; 32(4):693-8.
-
Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. J Pharmacol Exp Ther. 1992 Sep; 262(3):1168-72.
-
The heart and the regulation of renin. Circulation. 1987 Jan; 75(1 Pt 2):I130-3.
-
Role of cardiopulmonary mechanoreceptors in ADH release in normal humans. Hypertension. 1984 Nov-Dec; 6(6 Pt 1):832-6.
-
Orthostatic hypotension with brainstem tumors. Neurology. 1984 Sep; 34(9):1137-43.
-
Role of cardiovascular receptors on the neural regulation of renin release in normal men. Hypertension. 1983 Sep-Oct; 5(5):779-86.